Women, healthcare providers celebrate removal of “black box warning” from hormone replacement therapy options
The FDA's recent change of course on certain hormone therapies during menopause is welcome news for many women and their...
The FDA's recent change of course on certain hormone therapies during menopause is welcome news for many women and their...
The FDA has removed the black box label for hormone replacement therapy (HRT) used to address menopause symptoms, according to...
Our analysis highlighted three main dynamic interactions influencing demand and quality of care following the 2022 policy change: (1) shifts...